Tejas Savant

Stock Analyst at Morgan Stanley

(2.35)
# 2,651
Out of 5,026 analysts
233
Total ratings
43.18%
Success rate
-1.26%
Average return

Stocks Rated by Tejas Savant

Tempus AI
Aug 12, 2025
Maintains: Overweight
Price Target: $65$68
Current: $87.78
Upside: -22.53%
10x Genomics
Aug 12, 2025
Maintains: Overweight
Price Target: $18$17
Current: $11.82
Upside: +43.82%
Illumina
Aug 4, 2025
Maintains: Equal-Weight
Price Target: $100$105
Current: $95.52
Upside: +9.92%
Avantor
Aug 4, 2025
Maintains: Equal-Weight
Price Target: $15$12
Current: $14.79
Upside: -18.84%
Hologic
Jul 31, 2025
Maintains: Equal-Weight
Price Target: $65$69
Current: $69.87
Upside: -1.25%
NeoGenomics
Jul 30, 2025
Maintains: Equal-Weight
Price Target: $10$8
Current: $10.06
Upside: -20.48%
Cytek Biosciences
May 28, 2025
Maintains: Equal-Weight
Price Target: $9$7
Current: $3.96
Upside: +76.99%
Cryoport
May 5, 2025
Maintains: Equal-Weight
Price Target: $8$7
Current: $10.12
Upside: -30.83%
Adaptive Biotechnologies
May 5, 2025
Maintains: Equal-Weight
Price Target: $7$9
Current: $16.31
Upside: -44.82%
Maravai LifeSciences Holdings
Mar 25, 2025
Maintains: Equal-Weight
Price Target: $7$5
Current: $3.31
Upside: +51.06%
Maintains: Equal-Weight
Price Target: $16$20
Current: $77.95
Upside: -74.34%
Maintains: Overweight
Price Target: $176$185
Current: $181.69
Upside: +1.82%
Maintains: Overweight
Price Target: $245$250
Current: $204.48
Upside: +22.26%
Maintains: Overweight
Price Target: $647$678
Current: $538.92
Upside: +25.81%
Assumes: Equal-Weight
Price Target: $24$23
Current: $24.63
Upside: -6.62%
Maintains: Underweight
Price Target: $26$28
Current: $35.83
Upside: -21.84%
Maintains: Equal-Weight
Price Target: $32$21
Current: $7.80
Upside: +169.23%
Maintains: Equal-Weight
Price Target: $4$2
Current: $1.64
Upside: +21.95%
Maintains: Equal-Weight
Price Target: $80$40
Current: $13.27
Upside: +201.43%
Reiterates: Equal-Weight
Price Target: $6
Current: $0.98
Upside: +509.20%
Maintains: Overweight
Price Target: $11$10
Current: $4.38
Upside: +128.57%
Reiterates: Equal-Weight
Price Target: $2.75
Current: $3.08
Upside: -10.71%
Maintains: Equal-Weight
Price Target: $11$5
Current: $9.13
Upside: -45.24%
Maintains: Equal-Weight
Price Target: $11$10
Current: $2.16
Upside: +362.96%
Maintains: Overweight
Price Target: $80$73
Current: $65.46
Upside: +11.52%
Downgrades: Equal-Weight
Price Target: $350$250
Current: $178.52
Upside: +40.04%
Maintains: Equal-Weight
Price Target: $140$100
Current: $6.40
Upside: +1,462.01%